B -- Toluene Diisocyanate Effects

The Centers for Disease Control and Prevention (CDC) plans to award a sole source purchase order to The University of Cincinnati’s College of Medicine, Division of Immunology, Allergy Diagnostic Laboratory, located in Cincinnati, OH, for specialized serum analysis related to toluene diisocyanate antibodies. This laboratory is uniquely qualified as it is the only one conducting this test using IgG/IgE antibodies to diisocyanate antigens with a modified Avidin-biotin-complex (ABC) technology. The procurement will be made under the authority of FAR 6.302-1, and no competitive solicitation will be issued. However, firms capable of providing the required services are invited to submit written notifications to the CDC Contracting Officer within 10 days from the date this notice was published, though the decision to open competition rests solely with the Government. The contract is titled "B -- Toluene Diisocyanate Effects" and was posted on March 2, 2007. It falls under the NAICS code 541380. Inquiries and notifications related to this procurement may be directed to Contract Specialists Phil D Alexander and Russell T Oxford via email or phone as provided. This action underscores the specialized nature of the service required and the CDC’s intent to secure expertise from the uniquely qualified laboratory at the University of Cincinnati.